Summary
A 36-year-old man without evidence of previous liver disturbance developed hepatitis during recovery from bleeding duodenal ulcer and under therapy with a maintenance dose of 400 mg of cimetidine.
A 75-day interval between the drug administration and the development of hepatitis was observed. A liver biopsy specimen displayed acute hepatitis with spotty necrosis and accumulation of iron-containing pigment in portal histiocytes and Kupffer cells. Electron microscopic examination showed diffuse accumulation of bile pigment in liver cells. Smooth endoplasmic reticulum, mitochondria, and other organelles of the hepatocytes appeared otherwise normal. Rash and musculoskeletal pain suggested a hypersensitivity type of reaction. Results of functional tests returned to normal 24 days after drug withdrawal. Reexposure of the patient to the drug was followed by trasient reappearance of most symptoms and signs of the hepatic reaction. Until now, there has been no extensive study of liver morphology in cimetidine-induced hepatic injury.
Similar content being viewed by others
References
Züchner H: Cholestatische Hepatose unter Cimetidin. Dtsch Med Wochenschr 48:1788–1789, 1977
Villeneuve JP, Warner HA: Cimetidine hepatitis. Gastroenterology 77:143–144, 1979
Davidson CS, Leevy CM, Chamberlayne EC: Guidelines for Detection of Hepatotoxicity due to Drugs and Chemicals. Washington, NIH Publication 79-313, 1979
Orlandi F: Drug-induced acute liver disease.IN Toxic Injury of the Liver, Part B, E Farber, MM Fisher (eds). New York, Marcel Dekker, 1980, pp 655–685
Poulsen H, Christoffersen P: Atlas of Liver Biopsy. Copenhagen, Munksgaard, 1979
Osuga T, Mitamura K, Mashige F, Imai K: Evaluation of fluorimetrically estimated serum bile acid in liver disease. Clin Chim. Acta 75:81–90, 1977
Sharpe PC, Hawkins BW: Efficacy and safety of cimetidine. Long term treatment with cimetidine.In Cimetidine. Proceedings of the Second International Symposium onn Histamine H2-Receptor Antagonists. WL Burland, MA Simkins (eds). Amsterdam, Excerpta Medica, 1977, pp 358–366
Puurunen J, jPelkonen O: Cimetidine inhibits microsomal drug metabolism in the rat. Eur J Pharmacol 55:335–336, 1979
Serlin MJ, Sibeon RG, Mossman S, Breckenridge AM, Williams JRB, Atwood JL, Willoughby JMT: Cimetidine: Interaction with oral anticoagulants in man. Lancet 2:317–319, 1979
Whitfield JB, Moss DW, Neale G, Orme M, Breckenridge AM: Changes in plasma gamma-glutamyl transpeptidase activity associated with alterations in drug metabolism in man. Br Med J 1:316–318, 1973
Lilly JR, Hitch DC, Javitt NB: Cimetidine cholestatic jaundice in children. J Surg Res 24:384–387, 1978
Kruss DM, Littman A: Safety of cimetidine. Gastroenterology 74:478–483, 1978
Author information
Authors and Affiliations
Additional information
This study was supported by a research grant, 7901910.04, Consiglio Nazionale delle Ricerche, Roma.
Rights and permissions
About this article
Cite this article
Lorenzini, I., Jezequel, A.M. & Orlandi, F. Cimetidine-induced hepatitis. Digest Dis Sci 26, 275–280 (1981). https://doi.org/10.1007/BF01391643
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01391643